# Wave Life Sciences, Inc.: insider transactions

WVE · Nasdaq · CIK 1631574 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wve.md) · [Financials](/companies/wve/financials.md) · [Filings](/companies/wve/filings.md) · [Insiders](/companies/wve/insiders.md)

## All transactions: 3

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2025-12-11 | [GSK plc](/insiders/1131399.md) | 10% owner | Purchase (P) | 1,470,000 | $19.00 | $27.9m | [Form 4](/filings/0001999371-25-020336.md) |
| 2024-09-27 | [GSK plc](/insiders/1131399.md) | 10% owner | Purchase (P) | 2,791,930 | $8.00 | $22.3m | [Form 4](/filings/0001999371-24-012789.md) |
| 2023-12-07 | [GSK plc](/insiders/1131399.md) | 10% owner | Purchase (P) | 3,300,000 | $5.00 | $16.5m | [Form 4](/filings/0001999371-24-001192.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 16:33 ET. No prices; not investment advice.